Pregnancy outcomes of early detected gestational diabetes: a retrospective comparison cohort study, Qatar

Mohammed Bashir, Khaled Baagar, Emad Naem, Fadi Elkhatib, Noor Alshaybani, Justin C Konje, Abdul-Badi Abou-Samra, Mohammed Bashir, Khaled Baagar, Emad Naem, Fadi Elkhatib, Noor Alshaybani, Justin C Konje, Abdul-Badi Abou-Samra

Abstract

Objective: To compare pregnancy outcomes in patients with early versus usual gestational diabetes mellitus (GDM).

Design: A retrospective cohort study.

Settings: The Women's Hospital, Hamad Medical Corporation, Qatar.

Participants: GDM women who attended and delivered in the Women's Hospital, between January and December 2016. GDM was diagnosed based on the 2013-WHO criteria. The study included 801 patients; of which, 273 E-GDM and 528 U-GDM. Early GDM (E-GDM) and usual GDM (U-GDM) were defined as GDM detected before and after 24 weeks' gestation, respectively.

Outcomes: Maternal and neonatal outcomes and the impact of timing of GDM-diagnosis on pregnancy outcomes.

Results: At conception, E-GDM women were older (mean age 33.5±5.4 vs 32.0±5.4 years, p<0.001) and had higher body mass index (33.0±6.3 vs 31.7±6.1 kg/m2, p=0.0059) compared with U-GDM. The mean fasting, and 1-hour blood glucose levels were significantly higher in E-GDM vs U-GDM, respectively (5.3±0.7 vs 4.0±0.7 mmol/L, p<0.001 and 10.6±1.7 vs 10.3±1.6 mmol/L, p<0.001). More patients in the U-GDM were managed on diet alone compared with E-GDM (53.6% vs 27.5%, p<0.001). E-GDM subjects gained less weight per week compared with U-GDM (0.02±0.03 vs 0.12±0.03 kg/week, p=0.0274). Maternal outcomes were similar between the two groups apart from a higher incidence of preterm labour (25.5% vs 14.4%; p<0.001) and caesarean section (52.4% vs 42.8%; p=0.01) in E-GDM vs U-GDM, respectively. After correction for covariates; gestational age at which GDM was diagnosed was associated with increased risk of macrosomia (OR 1.06, 95% CI 1.00 to 1.11; p<0.05) and neonatal hypoglycaemia (OR 1.05, 95% CI 1.00 to 1.11; p<0.05).

Conclusion: Our data support the concept of early screening and treatment of GDM in high-risk patients. More data are needed to examine the optimal time for screening.

Keywords: early gestational diabetes; gestational diabetes; gestational weight gain; metformin; obesity.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

References

    1. World Health Organization. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. (Accessed 30 Jan 2018).
    1. ADA. 2. Classification and diagnosis of diabetes. Diabetes Care 2014;38:S8–S16.
    1. Blumer I, Hadar E, Hadden DR, et al. . Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013;98:4227–49. 10.1210/jc.2013-2465
    1. NICE guideline. Diabetes in pregnancy: management from preconception to the postnatal period. 2015.
    1. Hyperglycemia and Adverse Pregnancy Outcomes (HAPO). 2008.
    1. American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes-2018. Diabetes Care 2018;41(Suppl 1):S13–27. 10.2337/dc18-S002
    1. Sweeting AN, Ross GP, Hyett J, et al. . Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment. Diabetes Care 2016;39:75–81. 10.2337/dc15-0433
    1. Boriboonhirunsarn D, Kasempipatchai V. Incidence of large for gestational age infants when gestational diabetes mellitus is diagnosed early and late in pregnancy. J Obstet Gynaecol Res 2016;42:273–8. 10.1111/jog.12914
    1. Immanuel J, Simmons D. Screening and treatment for early-onset gestational diabetes mellitus: a systematic review and meta-analysis. Curr Diab Rep 2017;17:115 10.1007/s11892-017-0943-7
    1. Al-Thani AA, Bakri AH. Qatar Stepwise Report 2012 [Chronic Disease Risk Factor Surveillance]. 2012:1–124.
    1. Easmin S, Chowdhury TA, Islam MR, et al. . Obstetric outcome in early and late onset gestational diabetes mellitus. Mymensingh Med J 2015;24:450–6.
    1. Alunni ML, Roeder HA, Moore TR, et al. . First trimester gestational diabetes screening - change in incidence and pharmacotherapy need. Diabetes Res Clin Pract 2015;109:135–40. 10.1016/j.diabres.2015.04.027
    1. Buchanan TA, Xiang A, Kjos SL, et al. . What Is Gestational Diabetes? Diabetes Care 2007;30:S105–11. 10.2337/dc07-s201
    1. Harreiter J, Simmons D, Desoye G, et al. . IADPSG and WHO 2013 gestational diabetes mellitus criteria identify obese women with marked insulin resistance in early pregnancy. Diabetes Care 2016;39:e90–2. 10.2337/dc16-0200
    1. Bozkurt L, Göbl CS, Pfligl L, et al. . Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the international association of diabetes and pregnancy study groups criteria. J Clin Endocrinol Metab 2015;100:1113–20. 10.1210/jc.2014-4055
    1. Desoye G, Nolan CJ. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy. Diabetologia 2016;59:1089–94. 10.1007/s00125-016-3931-6
    1. Clausen T, Burski TK, Øyen N, et al. . Maternal anthropometric and metabolic factors in the first half of pregnancy and risk of neonatal macrosomia in term pregnancies. A prospective study. Eur J Endocrinol 2005;153:887–94. 10.1530/eje.1.02034
    1. Kitwitee P, Limwattananon S, Limwattananon C, et al. . Metformin for the treatment of gestational diabetes: an updated meta-analysis. Diabetes Res Clin Pract 2015;109:521–32. 10.1016/j.diabres.2015.05.017
    1. Butalia S, Gutierrez L, Lodha A, et al. . Short- and long-term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med 2017;34:27–36. 10.1111/dme.13150
    1. Riskin-Mashiah S, Younes G, Damti A, et al. . First-trimester fasting hyperglycemia and adverse pregnancy outcomes. Diabetes Care 2009;32:1639–43. 10.2337/dc09-0688

Source: PubMed

3
Tilaa